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EDITORIAL REVIEW 
Dialysis hypotension: A hemodynamic analysis 
To understand dialysis hypotension one must be familiar with 
several aspects of cardiovascular physiology. Accordingly, this 
discussion will begin by examining the normal compensatory 
mechanisms to hypovolemia. The hemodynamic changes ac-
companying increased body temperature and eating will also be 
discussed. The focus will then shift to uremic patients and 
dialysis. How functioning of the autonomic nervous system 
may be altered in uremia will be examined. Then this review 
will analyze how certain dialysis techniques can adversely 
affect some of the compensatory hemodynamic responses to 
hypovolemia, and how increased body temperature during 
dialysis and ingestion of food or glucose can have undesirable 
hemodynamic consequences. Finally, a set of practical recom-
mendations for optimizing blood pressure response during 
dialysis therapy will be presented. 
Physiologic responses to hypovolemia 
Compensatory responses to acute hypovolemia include 
mechanisms that decrease venous capacity (which helps main-
tain cardiac filling), mechanisms that increase cardiac contrac-
tility and rate (which optimize cardiac output under conditions 
of decreased filling), and mechanisms that increase vascular 
resistance (which decreases venous capacity by an indirect 
mechanism, which redistributes the cardiac output among the 
various vascular beds to ensure perfusion of critical organs, and 
which increases pressure in the proximal arterial system). 
Decreased venous capacity 
A substantial percentage of the total blood volume is located 
in the venous system, the capacity of which can change 
markedly. Translocation of this blood volume centrally during 
hypovolemia can result in a relative increase in the rate of 
venous return [1]. During subacute hemorrhage, in addition to 
redistribution of what blood volume there is, actual refilling of 
the plasma compartment with fluid and electrolytes from ad-
joining tissue spaces and with protein from thoracic lymph [2] 
can also help maintain venous return. 
Control of vascular capacity. There are two mechanisms 
whereby the capacity of a regional circulatory bed can be 
reduced: active, reflexly mediated venoconstriction and de-
creased regional filling. The extent to which active, (neurogen-
ically or hormonally-mediated) venoconstriction occurs in hu-
mans during hypovolemia is controversial. A more important 
mechanism is decreased regional filling. How decreased re-
gional filling can increase venous return, the so-called DeJager-
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Krogh phenomenon [reviewed in 1] is illustrated in Figure 1. 
When the resistance in vessels supplying a compliant vascular 
bed is increased, flow is reduced as well as downstream 
distending pressure. Passive recoil of the venous bed occurs, 
reducing its capacity. A portion of the blood volume previously 
in the venous bed is shifted back towards the heart, increasing 
cardiac filling. In a computer simulation of the circulatory 
system, increased venous return due to changes in vascular 
resistance has been shown to have a very strong effect on the 
level of cardiac output [3]. 
Regional circulations which decrease their venous capacity 
during hypovolemia. The two vascular beds that participate 
most extensively in decreased venous capacity during hypo-
volemia are the splanchnic and cutaneous circulations. 
The splanchnic bed is composed of the circulation to the 
spleen, liver, and intestines. Although the relative contributions 
of spleen, liver, and intestines to splanchnic-mediated volume 
redistribution are not known, the fact that splanchnic capacity 
decreases during hypovolemia is well established [4-6]. Al-
though the removed, perfused spleen is incapable of changing 
its volume [7], the in situ human spleen does appear to contract 
on change to upright posture and during exercise, with the 
addition of previously sequestered erythrocytes to the circula-
tion [8]. 
Reduction in splanchnic capacity during hypovolemia can be 
due either to active venoconstriction or to reduced inflow as 
discussed above. Splanchnic veins are extensively innervated 
with both alpha- and beta-adrenergic fibers. It has been sug-
gested that increases in plasma epinephrine levels during severe 
hypovolemia might act to reduce splanchnic capacity [9, 10]. 
Splanchnic resistance vessels are innervated by alpha-adrener-
gic fibers, and reflex increases in splanchnic resistance during 
hypovolemic stress, by virtue of reducing splanchnic flow and 
intrasplanchnic pressure, may also help empty the splanchnic 
circulation and augment venous return [11]. 
The cutaneous circulation is an extremely important blood 
reservoir in man, the volume of which can increase markedly 
during heat stress and which can contract during hypovolemia. 
Cutaneous vascular capacity is controlled primarily by distend-
ing pressure as modulated by resistance vessel tone; in humans 
a role for reflex venoconstriction in the cutaneous bed is 
controversial, [reviewed in 1]. 
During hypovolemia, flow as well as downstream distending 
pressure are reduced in several other circulatory beds which 
receive a substantial portion of the cardiac output (that is, 
muscle and kidney). However, the compliance of the muscle 
and kidney beds is such that their vascular capacity decreases 
only minimally during hypovolemia, with minimal augmenta-
tion of venous return. 
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Fig. 1. The Dejager-Krogh phenomenon illustrated. In the top panel, 
resistance vessel tone is low, and flow through the compliant vascular 
bed is high; this increases distending pressure and causes sequestration 
of blood in the venous bed. In the lower panel. resistance vessel tone 
has been increased. Now flow and distending pressure are reduced. The 
vascular capacity decreases due to passive recoil. and the previously 
sequestered blood is translocated back toward the heart. 
Increased heart rate and contractility 
Heart rate. The normal cardiac response to hypovolemia is 
an early tachycardia followed by a reduction in heart rate back 
to a normal, or even a subnormal level [12]. Intuitively it would 
seem that, as long as stroke volume is maintained, an increase 
in cardiac rate should result in an important increase in cardiac 
output and blood pressure. However, during hypovolemia 
changes in cardiac rate have been shown to be of minor 
importance. In unanesthetized sheep, for example, the hemo-
dynamic response to slow hemorrhage is unchanged when the 
normal increase in heart rate is prevented by administration of 
propranolol [13]. In dogs, cardiac denervation eliminates the 
heart rate response to hemorrhage, but has no effect on the 
blood pressure response [14]. Similar findings have been ob-
tained in humans in whom hypotension was induced by lower 
body negative pressure; blocking the late slowing of the heart 
rate with atropine had no effect on the blood pressure response 
[12]. In another study in humans, pharmacologic blockade of 
cardiac reflexes did not alter blood pressure response to grav-
itational stress [15]. 
Contractility. A second hemodynamic mechanism potentially 
capable of increasing cardiac output in hypovolemia is in-
creased cardiac contractility. Increases in cardiac contractility 
can increase cardiac output by increasing stroke volume; the 
latter is effected by a more complete emptying of the heart 
(reduction in end-systolic volume), and a quicker contraction 
and relaxation of the heart, allowing a relative increase in the 
diastolic filling time and end-diastolic volume. Again, however, 
there is evidence to suggest that increases in cardiac inotropy 
are not very important during hypovolemic conditions: as noted 
above, blockade of beta-adrenergic responses with propranolol 
had little effect on the hemodynamic response of unanesthe-
tized sheep to slow hemorrhage [13]. In conscious dogs, beta-
adrenergic blockade [16] or cardiac denervation [14] have 
minimal effect on the hemodynamic response to hemorrhage. 
It appears, therefore, that in hypovolemia, cardiac output is 
determined primarily by the amount of cardiac filling; the heart 
can pump out only what flows in, and optimizing pump perfor-
mance under conditions of severely decreased filling is of very 
limited benefit [reviewed in 1. 3]. 
Increased vascular resistance 
Increased peripheral vascular resistance during hypovolemia 
has three effects: (1) Increased resistance to the splanchnic and 
cutaneous beds effects a partial emptying of these compliant 
vascular beds with a relative increase in venous return as 
discussed above, (2) flow is reduced to the renal and skeletal 
muscle beds also, which allows a larger portion of the cardiac 
output to be directed to more critical regional circulations, and 
(3) because overall resistance is increased, the decrease in 
pressure in the proximal arterial circulation due to reduced 
cardiac output is minimized. 
Important cardiovascular reflexes during hypovolemia 
Cardiopulmonary and pressoreceptors 
The two principal reflex arcs that affect vascular tone during 
hypovolemia involve the cardiopulmonary receptors (located in 
the atria and in the region of the main pUlmonary veins) and the 
pressoreceptors (located in the aortic arch and carotid bifurca-
tion regions). In the resting state, both sets of receptors exert a 
tonic inhibition of sympathetic outflow to resistance vessels in 
skeletal muscle and skin. The activity of these reflexes can be 
measured directly by microneurography of the peroneal nerve 
region [17, 18]. Whereas control of resistance vessels by 
cardiopulmonary/pressoreceptors is well established, it is not 
known to what extent veins are similarly regulated. 
The cardiopulmonary receptors are believed to be a first line 
of defense against hypovolemia; a change in cardiopulmonary 
receptor activity can be documented even at levels of mild 
hypovolemia, under conditions where a reduction in pulse 
pressure or mean arterial pressure is not observed. When 
cardiopulmonary receptors sense a decrease in cardiac filling 
pressure and/or volume, they become "de-activated", that is, 
they cease their tonic inhibition of sympathetic outflow, and 
sympathetic tone to muscle and cutaneous arterioles is in-
creased. As a result, cutaneous and skeletal muscle flow are 
reduced. A reduction in cutaneous capacity follows due to the 
passive mechanisms discussed above, with redistribution of 
some of the cutaneous blood volume towards the heart. The 
decrease in venous return is thereby minimized, and the fall in 
cardiac output is mitigated. Although cardiac output does fall 
slightly, the pulse pressure and mean arterial pressure are 
maintained because the increases in muscle and cutaneous 
resistance effect a rise in the total peripheral resistance. 
At such mild, sUbhypotensive levels of hypovolemia, de-
activation of cardiopulmonary receptors is associated with a 
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modest rise in plasma norepinephrine levels [19, 20]. Unless the 
duration of hypovolemia is prolonged [21], there is no change in 
plasma levels of renin activity, aldosterone, or vasopressin [19, 
22]. There is minimal effect on splanchnic resistance, and 
splanchnic blood flow decreases only slightly if at all [23]. 
With more severe hypovolemic stress, venous return falls yet 
further; there is a more pronounced fall in cardiac output, to the 
extent that a fall in pulse pressure and mean arterial pressure 
result. At this point the decrease in pulse pressure and mean 
arterial pressure is sensed by the aortic and carotid body 
pressoreceptors. These pressoreceptors then become "de-acti-
vated" as well, diminishing their usual tonic inhibition of 
sympathetic activity. Resistance arterioles in muscle and skin 
constrict even further, and a number of new hemodynamic 
changes are seen; heart rate and contractility increase. The 
resistance of other circulatory beds not under baseline tonic 
sympathetic inhibition, such as of the splanchnic and renal 
circulations, rises also [23-25]. Plasma levels of norepinephrine 
rise further, and increases in plasma renin, and aldosterone, and 
then vasopressin are seen [4, 26, 27] . With severe hypotension, 
the adrenal medulla comes into play, and plasma adrenaline 
levels rise also. The increase in splanchnic resistance now 
effects partial emptying of the large splanchnic blood compart-
ment, mitigating the decrease in venous return. Also , the 
decreases in splanchnic and renal blood flow allow a greater 
portion of the cardiac output to supply the coronary and 
cerebral circulations. Vasopressin may play and important 
adjunct role here; whereas vasopressin constricts most periph-
eral circulations, it may act to dilate cerebral arteries by an 
endothelium-dependent mechanism [28], and help ensure main-
tenance of adequate brain blood flow. 
Other reflexes 
Venoarterial reflex. The venoarterial reflex functions to limit 
venous pooling. The afferent sensor in the vein or venule is 
activated in response to venous distension. The efferent limb 
constricts the resistance arterioles immediately upstream. As a 
result, flow through the distended vein is reduced, and the vein 
empties due to passive recoil [29]. Venoarterial reflexes are not 
particularly important in the vascular response to hypovolemia, 
but may be very important (in conjunction with the presence of 
venous valves) in the maintenance of venous return on stand-
ing. The presence of the venoarterial reflex is one explanation 
why some patients with complete spinal cord transection (in 
whom cardiopulmonary and pressoreceptor function has been 
seriously compromised) have relatively little orthostatic hypo-
tension [30, 31]. 
Reflexes affecting the limb muscles. Limb muscles are of 
great importance in maintaining venous return on standing via 
their perivascular support and pumping actions. The severe 
hypotension that occurs when standing is attempted after 
prolonged bedrest or after spaceflight is thought to be due 
largely to a diminution in leg muscle tone; in such circum-
stances the normally non-compliant circulatory bed in leg 
muscle can be transformed into one with high compliance, and 
an important amount of blood can be sequestered there on 
standing [32]. The importance of limb muscles is illustrated by 
the fact that the fall in blood pressure on passive tilting, when 
the leg muscles do not contract, is much greater than on 
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Fig. 2. Increase in rectal temperature as a result of tilting to 45°. A 
one-hour supine period is followed by a 70-minute tilt period, followed 
by a return to the supine position. (Modified with permission from [32)). 
standing, when the pumping action of muscle contraction is 
thought to augment venous return. 
Hemodynamic responses to thermal stress 
Humans are unique in that they are able to markedly increase 
skin blood flow as a means of dissipating excess body heat. 
Cutaneous blood flow, normally several hundred ml/min in a 
thermoneutral environment, can decrease to near zero in the 
cold, and can increase to the range of 7 to 8 liter/min under 
conditions of maximum heat stress [33]. The increased cutane-
ous flow during heat stress requires a large increase in cardiac 
output to occur, but the augmented cutaneous flow occurs 
partially at the expense of flow to the splanchnic and renal 
circulations, which are reduced. During heat stress, decreased 
cutaneous vascular resistance (which causes increased cutane-
ous flow and venous pressure) is associated with a marked 
sequestration of blood in the subpapillary venous plexus [33] . 
The reflex control of various regional circulations during heat 
stress is complex and not completely understood (see ref [33] 
for a complete discussion). Increases in core body temperature, 
sensed primarily in the hypothalamus, result in active cutane-
ous dilatation, the mechanism of which has not been completely 
elucidated [33]. Sweating may be associated with release of a 
vasodilator peptide, and in anhidrotic patients, cutaneous va-
sodilatation during heat stress is impaired [34] . The reflex 
pathways that cause splanchnic and renal vasoconstriction 
during heat stress have not been characterized. 
There are important interactions between body temperature 
and baroreflex regulation of cutaneous blood flow. For exam-
ple, in a thermoneutral environment, changing from a supine to 
an upright posture results in a baroreflex-mediated cutaneous 
vasoconstriction. The decreased cutaneous blood flow that 
results leads to a slowed rate of body heat loss and an increase 
in core body temperature (Fig. 2) [32]. Baroreflexes continue to 
modulate cutaneous blood flow even under conditions of heat 
stress; however, as cutaneous blood flow is increased by rises 
in core body temperature, baroreceptor action becomes pro-
gressively less able to reduce cutaneous blood flow [33, 35, 36]. 
As a result, the combined application of heat stress and 
hypovolemia usually results in severe hypotension [33]. 
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Table 1. Alteration of cardiopulmonary/pres so-receptor reflex 
function in non-uremic individuals 
Impairment 
I. Structural heart damage 
Severe congestive heart 
failure [171, 172] 
Hypertension with LVH [173) 
2. Elderly [174, 175] 
3. Diabetes [177] 
4. Autonomic neuropathies 
5. Drugs 
Clonidine [179] 
Propranolol [27] 
Diltiazem [180] 
Augmentation 
I. Young athletes [170] 
2. Early hypertension [176) 
3. Nifedipine [178] 
Hemodynamic responses to ingestion of food or glucose 
In normal healthy persons the ingestion of a meal is not 
associated with changes in blood pressure, but is accompanied 
by a marked increase in cardiac output and decrease in total 
peripheral vascular resistance [37, 38]. There is a marked 
increase in splanchnic blood flow [39], and a decrease in 
forearm blood flow [38]. Whereas an early study suggested that 
it was protein, rather than glucose ingestion that was responsi-
ble for the increase in splanchnic blood flow [40], in many 
subsequent studies, the hemodynamic alterations following a 
meal are best reproduced by glucose ingestion. Protein inges-
tion, in fact, may be associated with minimal hemodynamic 
effects [41]. 
Whereas food ingestion in healthy subjects is hemodynami-
cally well-tolerated, postprandial hypotension is observed not 
uncommonly in patients with severe autonomic nervous system 
disorders [42] and in the elderly [43, 44]. The hemodynamic 
mechanism of post-prandial hypotension in such patients may 
be due to an inability to increase cardiac output under condition 
of an obligatory increase in splanchnic blood flow and reduced 
total peripheral vascular resistance [38, 39]. 
The question of which mediators are involved in post-pran-
dial hypotension has great potential therapeutic importance. 
One candidate is adenosine: in dogs food-induced jejunal hy-
peremia has been shown to be an adenosine-mediated phenom-
enon, preventable by pretreatment with an adenosine receptor 
blocker [45]. Caffeine, which has some adenosine receptor 
blocking effects, attenuates postprandial hypotension in pa-
tients with autonomic failure [46]. In other studies, pretreat-
ment with a somatostatin analogue has been shown to prevent 
postprandial hypotension [42]. Whether insulin has a causative 
role is controversial [41]. 
Impaired autonomic reflexes in uremia 
It is now well recognized that some sort of autonomic 
impairment occurs in a substantial proportion of hemodialysis 
patients. Because cardiopulmonary and/or pressoreflex func-
tion is impaired in patients with congestive heart failure, in 
hypertensives, in the elderly, and in diabetics (Table 1), it is not 
always possible to know whether some or any of the reported 
defects are due to uremia per se. One theme running through 
many of the reported studies is an attempt to link the occur-
rence of an autonomic defect to a population subject to frequent 
hypotensive episodes during hemodialysis. In this regard, the 
findings are not conclusive and often contradictory. 
Tests focusing on heart rate changes 
One approach to the study of autonomic reflexes in uremic 
patients has been the evaluation of heart rate changes. Some 
studies have focused on the spontaneous variation in heart rate, 
others on the heart rate response to the Valsalva maneuver, or 
on the heart rate response to pharmacologically or posturally 
induced changes in blood pressure. Heart rate control in uremia 
is definitely impaired [47-51]. Of particular interest is an early 
study that divided patients into those prone to hypotension 
during dialysis and those not. It was found that the change in 
R-R interval factored by change in blood pressure after amyl 
nitrite inhalation was less in the hypotension-prone group than 
in hypotension-resistant group [51]. Unfortunately, a number of 
subsequent studies have failed to link heart rate impairment 
with a hypotension-prone dialysis population [52-54]. Given the 
evidence (discussed above) that heart rate changes may be of 
limited importance to the maintenance of blood pressure in 
hypovolemia, and the fact that heart rate abnormalities can 
exist independently of other defects of the autonomic nervous 
system functioning [55-57], the failure to implicate heart rate 
defects in the causation of dialysis hypotension is not surpris-
ing. The heart rate abnormalities in dialysis patients do not 
appear to progress with time [58] and are improved greatly if not 
completely normalized in renal transplant recipients [55]. 
Tests focusing on blood pressure responses 
More relevant tests of autonomic function in dialysis patients 
are those evaluating the response of either the capacitance or 
resistance vessels to simulated hypovolemia. Studies incorpo-
rating such tests have been published, but they are few in 
number, and interpretation is usually complicated by the fact 
that the blood volume in dialysis patients can vary enormously. 
One simple indicator of global autonomic function is the blood 
pressure response to standing or tilting. Mallamaci et al, study-
ing dialysis patients in general, found an increase in MAP on 
standing [55]. Lilley, Golden and Stone [51] and Nakashima and 
colleagues [54] found no statistically significant difference in the 
MAP response to tilting between hypotension-prone and hy-
potension-resistant dialysis patients [54]. However, there is one 
positive study in this area: diabetic dialysis patients, known to 
be susceptible to dialysis-induced hypotension, were found to 
exhibit a fall in MAP on tilting, whereas in non-diabetic dialysis 
patients the MAP increased with tilting [59]. In that study the 
primary reason for the fall in MAP on tilting in diabetic dialysis 
patients was a failure of peripheral vascular resistance to 
increase [59]. 
One response associated with impaired baroreflex effect on 
the systemic vasculature is the so-called "square wave" pattern 
of the blood pressure after Val salva maneuver, often seen in 
patients with marked congestive heart failure [60]. Heber et al 
found such a "square wave" response in 9 of 10 hypotension-
prone dialysis patients. Interestingly, none of these patients 
evidenced a fall in blood pressure on tilting [61]. 
Tests focusing on norepinephrine 
A different approach to the study of autonomic functioning is 
measurement of plasma levels of catecholamines and of dopam-
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ine beta-hydroxylase, an enzyme involved in catecholamine 
synthesis. 
In hemodialysis patients, results pertaining to catecholamine 
levels and turnover are confusing and contradictory. One group 
of findings is consistent with an hypothesis of sympathetic 
hyperactivity [51], due perhaps to loss of tonic sympathetic 
inhibition by baroreceptors which have become dysfunctional 
(so-called "de-afferentation"). Results in support of sympa-
thetic hyperactivity include a progressive rise in basal plasma 
levels of norepinephrine in dialysis patients as the number of 
years on dialysis increases [62]. Also there is a progressive 
decline in the density of platelet alpha-adrenoreceptors [62], 
postulated to be due to down-regulation in response to chronic 
sympathetic hyperstimulation. Similarly, there is a progressive 
diminution in the blood pressure rise to infused phenylephrine, 
postulated to be due to decreased end-organ responsiveness, 
again, secondary to chronic hyperstimulation [62]. The hypoth-
esis of sympathetic hyperactivity is further supported by sev-
eral reports of elevated basal plasma levels of norepinephrine or 
dopamine beta-hydroxylase in dialysis patients [reviewed in 
62]. Two groups have attempted to quantify norepinephrine 
turnover rates by infusing norepinephrine and measuring the 
resultant steady-state plasma levels [63, 64] . These studies 
demonstrated that plasma norepinephrine clearance and the 
plasma norepinephrine appearance rate were both increased in 
dialysis patients. 
On the other hand, normal or subnormal basal plasma nor-
epinephrine and dopamine beta hydroxylase levels in dialysis 
patients have also been reported [reviewed in 65], and a recent 
study measuring norepinephrine turnover using tracer tech-
niques, with turnover measurements performed at physiologic 
plasma norepinephrine concentrations, found that norepineph-
rine turnover is actually decreased in dialysis patients [65] . For 
the moment then, the hypothesis of sympathetic hyperactivity 
in dialysis patients is controversial and may not be correct. 
In several types of autonomic neuropathy the plasma norepi-
nephrine response to tilting is blunted or abolished, evidence of 
damage to peripheral sympathetic nerve terminals or to the 
baroreflex arc [66, 67]. As reviewed in Table 1, congestive heart 
failure, L VH, and other conditions have been associated with 
impaired baroreflex functioning, including at times a blunted 
plasma norepinephrine response to simulated hypovolemic 
stress [26]. In dialysis patients, some investigators find that the 
rise in plasma norepinephrine to tilt or to upright posture is 
preserved [68-70], even in those patient subgroups in which 
dialysis hypotension commonly occurs [54]. Others find an 
impaired rise in dopamine beta hydroxylase to tilt [71]. In 
diabetic dialysis patients, both plasma norepinephrine response 
and blood pressure response to tilting are abnormal [59]. 
Abnormal secretion/control of plasma vasoactive hormones in 
uremic patients 
There is a sizeable literature concerning abnormal basal or 
stimulated plasma levels of vasoactive hormones other than 
norepinephrine in dialysis patients, including renin activity, 
aldosterone, arginine vasopressin , atrial natriuretic peptide, 
parathyroid hormone, calcitonin gene-related peptide (CORP), 
and prostaglandin E2 • A detailed evaluation of all of these 
reports is beyond the scope of the present review. 
Renin response to hypovolemia is occasionally blunted in 
dialysis patients [72], although this is controversial [73, 74], and 
is severely compromised in nephrectomized patients. The ques-
tion arises whether or not loss of renin response might impair 
the hemodynamic response to hypovolemia. Several recent 
studies suggest that this is not the case. For example, whereas 
acute nephrectomy in anesthetised dogs impairs the blood 
pressure response to hemorrhage [75], in conscious dogs stud-
ied one week after nephrectomy, hemodynamic responses to 
hemorrhage or isolated ultrafiltration are well-preserved despite 
a severely blunted increase in plasma renin activity [76] . 
Nephrectomized dialysis patients have a normal hemodynamic 
response to upright posture [77] . It remains a possibility that the 
renin-angiotensin system, an important back-up system in hy-
povolemic stress, may become important in dialysis patients in 
whom other sympathetic compensatory responses are dimin-
ished. Isolation of the renin effect is difficult, because loss of 
renin response to hemodialysis is often a marker for barorecep-
tor dysfunction, and usually occurs together with loss of 
compensatory sympathetic responsiveness [72]. 
Plasma vasopressin levels have been shown to increase 
acutely during dialysis in response to transient reductions in 
blood volume [78]. In some dialysis patients plasma vasopressin 
levels fail to increase during dialysis [79]. Whether the failure of 
vasopressin levels to rise contributes to dialysis hypotension is 
unknown. Atriopeptin, a substance which may interfere with 
baroreceptor function (this is controversial [80-82]), is found in 
increased amounts in uremic plasma [83, 84], as is parathyroid 
hormone; both atriopeptin and parathyroid hormone have va-
sodilatory properties. Levels of calcitonin gene-related peptide 
are increased in uremic patients [85], and calcitonin gene-
related peptide has extremely potent vasodilator activity [86]. 
The clinical implications of abnormal plasma levels of atriopep-
tin, parathyroid hormone, and calcitonin-gene-related peptide 
in uremic patients are not known, as these abnormalities have 
not been linked convincingly to the occurrence of dialysis 
hypotension. 
Compensatory responses to hypovolemia: Impairment by 
specific aspects of dialysis treatment 
Having reviewed the principal responses to hypovolemia and 
their possible derangement in uremia, it is useful to analyze how 
each might be compromised by specific aspects of dialysis 
treatment. 
Plasma refilling rate 
During the course of a three or four-hour hemodialysis 
session, an ultrafiltrate volume equal in magnitude to the entire 
plasma volume often must be removed; that this usually can be 
accomplished without attendant hypotension is a tribute to the 
effectiveness of normal compensatory hemodynamic mecha-
nisms, and especially to the effectiveness of plasma refilling. 
For example, removal of 3 liters of ultrafiltrate over a three-
hour period causes a mere 17% decrease in the plasma volume 
[87]. 
Effect of ultrafiltration rate and of dialysis solution sodium 
level. The rate of ultrafiltration and the dialysis solution sodium 
concentration are the most important co-determinants of the 
plasma refilling rate [87, 88]. For example, in dogs, when 
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dialysis solution sodium level is set well below the plasma 
sodium value, the rate of plasma volume reduction is greatly 
increased [89]. Similarly, in humans, use of a low sodium 
dialysis solution has been associated with an inordinately rapid 
decrease in the plasma volume [88]. Predialysis hyponatremia 
may be of some consequence as well: In dogs rendered hypona-
tremic prior to dialysis, removal of excess body water by 
isolated ultrafiltration is difficult because an inordinately high 
percentage of total body water may be in the extravascular 
compartment [90]. 
Acetate. At least three studies have suggested that the plasma 
refilling rate is decreased during acetate dialysis [91-93]. The 
proposed explanation is an alteration of Starling forces in the 
capillary bed-acetate-induced arteriolar dilatation would re-
sult in increased hydrostatic pressure in the capillary bed 
(which would inhibit refilling). An alternative (highly specula-
tive) interpretation of the data, could be that the hypotension 
associated with acetate might have resulted in splenic contrac-
tion with addition of erythrocyte-rich blood to the circulation; 
the increase in hematocrit that would result could be interpreted 
(erroneously) as plasma volume contraction or "decreased 
refilling." However, several other studies report no decrease in 
the plasma refilling rate with acetate dialysis [94, 95]. 
Other factors. The plasma refilling rate is affected by the 
amount of interstitial volume, in that when interstitial fluid 
overload is present, refilling proceeds at a faster rate than when 
a patient is near "dry weight" [87]. From Starling principles, 
one would expect that the plasma refilling rate would be higher 
also in patients with higher predialysis plasma protein concen-
trations, which would translate into higher oncotic pressures. 
Patients with a low hematocrit predialysis appear to be inordi-
nately susceptible to dialysis hypotension, in that the problem is 
ameliorated by blood transfusion [96] , but the hemodynamic 
mechanism of the hematocrit effect has not been clarified. 
Perhaps a higher red blood cell mass results in an improved 
ability to maintain blood volume during ultrafiltration. Because 
urea traverses the various body water compartments quickly, 
decreases in the plasma urea level during hemodialysis do not 
affect the rate of contraction of the plasma volume [97, 98]. 
Venous capacity 
Dialysis patients with any of the conditions listed in Table 1 
might not be able to reduce venous capacity during hypo-
volemia due to baroreceptor dysfunction. Anemia may also 
playa role, in that anemic uremic patients have been found to 
have flabby veins the compliance of which decreases after 
erythropoietin treatment [99]. 
Venous pooling during dialysis. Evidence that peripheral 
pooling of the blood volume may be occurring during dialysis 
was first provided by Chen and Chaignon and their colleagues 
[100]. They measured end-diastolic cardiac volume echocardio-
graphically, and total blood volume from plasma volume e251_ 
albumin) and a simultaneously determined hematocrit. The 
ratio of end-diastolic cardiac volume to total blood volume 
(EDVrrBV) was taken to be a measure of peripheral pooling. 
An increased EDVrrBV ratio would reflect a central shift ofthe 
blood volume whereas a decreased EDVrrBV ratio would 
signal peripheral pooling. During isolated ultrafiltration the 
EDVrrBV increased [100], whereas during regular acetate 
hemodialysis EDV/TBV decreased [101]. In another study, 
Leenen et al found that with acetate hemodialysis there was an 
early decrease in left ventricular end-systolic dimensions, sug-
gestive of peripheral blood pooling due to venodilatation [102]. 
Bradley measured forearm venous tone during dialysis and 
found it to be decreased [103]. Maeda's group [104], measuring 
hemodynamic parameters in nine patients who habitually de-
veloped sudden onset hypotension during acetate dialysis , 
found that the hypotension was not preceded by a fall in blood 
volume or by a fall in peripheral vascular resistance, but was 
heralded by a decreased cardiac output. They theorized that the 
decrease in cardiac output was due to decreased filling second-
ary to a peripheral shift in blood volume (possibly due to 
venodilatation) . 
Dialysis related factors that might inappropriately increase 
venous capacity: a.) Acetate. Acetate is a powerful vasodila-
tory substance which acts to increase splanchnic blood flow 
through an adenosine-mediated action [105]. In at least some 
vessels acetate may cause vasorelaxation via a cyclic AMP-
related , adenosine-independent action [106, 107]. In conscious 
dogs , acetate dialysis is associated with a fall in the central 
venous pressure [108]. Acetate might increase venous capacity 
by either a direct effect on veins or by a vasorelaxant effect on 
splanchnic and cutaneous resistance vessels leading to in-
creased flow and distending pressures in these two circulatory 
beds. At first glance it is difficult to envision an adverse effect of 
acetate on venous return , since acetate dialysis is usually 
associated with an increased cardiac output [109]; however, a 
decrease in cardiac filling need only be relative: if peripheral 
vascular resistance decreases by 20%, for example, an increase 
in cardiac output of similar magnitude is required to maintain 
the blood pressure. If the cardiac output is capable of increasing 
by only 10% due to insufficient venous return, then hypotension 
may result ; both the decrease in peripheral vascular resistance 
and reduced venous return are contributory factors to hypoten-
sion in such an instance. 
Except for the study by Bradley et aI, in which forearm 
venous tone decreased during both bicarbonate and acetate 
dialysis [103], all reports suggesting venodilatation during dial-
ysis [101, 102, 104] have involved use of acetate dialysis 
solution. In fact, in the report by Leenen et al [102], evidence 
for venodilatation was absent when bicarbonate dialysis solu-
tion was used. 
In some reports of acetate dialysis, decreased cardiac filling 
has not been documented directly, but the cardiac output has 
been found to be decreased . A decreased cardiac output per se 
is not evidence for increased venous capacity; alternative cause 
could be a decreased plasma refilling rate or diminished cardiac 
contractility; however, the results bear highlighting, as they are 
different from the usual finding of an increased cardiac output 
with acetate dialysis. One such observation was in septic 
patients during acetate dialysis by Leunissen et al [110]. In 
another study, a comparison of hemodialysis, hemofiltration, 
and hemodiafiltration using either acetate or bicarbonate as 
base , use of acetate with each of the three treatment modalities 
was associated with a decrease in cardiac output; this effect was 
not seen when bicarbonate was employed [Ill]. 
b.) Body temperature. A slight increase in core body temper-
ature has been noted to occur during dialysis [112]. The reason 
for this is not clear; one suggested cause has been the induction 
and release of monokines (among them interleukin-I and tumor 
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necrosis factor) during dialysis due to blood-membrane inter-
actions or to contaminated dialysis solution (see below). An 
alternative, ingenious explanation for the rise in core body 
temperature during dialysis is based on the interaction between 
baroreceptor and thermal control of skin blood flow discussed 
above [32], and has been proposed by Gotch, Keen and Yarian, 
who termed it "thermal amplification" of dialysis hypotension 
[113]. The idea is as follows: even if metabolic heat production 
during dialysis is unchanged, hemodynamically mediated con-
striction of cutaneous vessels in response to volume depletion 
early during dialysis might reduce body heat loss , leading to 
build up of core body heat, and ultimately, to reflex dilatation of 
the cutaneous circulation [113]. The sudden opening of cutane-
ous blood vessels during the latter part of a dialysis session 
would result in an increased cutaneous capacity. 
c.) Ingestion of food. As reviewed above, during hypo-
volemia, the body attempts to conserve blood flow to vital 
organs, limiting flow to the splanchnic and other circulations. 
Feeding a patient during a dialysis session upsets these conser-
vation measures because feeding results in an obligatory in-
crease in splanchnic blood flow with splanchnic blood pooling 
and decreased venous return. The association of food ingestion 
with dialysis hypotension now has been well documented [114, 
115] . 
d.) Dialysis solution sodium level. Use of a low sodium 
dialysis solution could conceivably cause venous pooling, al-
though there is no definite evidence in support of such a 
hypothesis. Acute changes in sodium level impair baroreceptor 
function in experimental animals [116]. Dialysis using a low 
sodium dialysis solution has been reported to elevate prosta-
glandin E2 1evels [117] and the latter substance is known to have 
venodilatory properties. A low sodium dialysate has been 
shown to be a cofactor with acetate with respect to increasing 
the occurrence of postdialysis orthostatic hypotension [118]. 
On the other hand, acute hyponatremia contracts , rather than 
dilates certain isolated vascular beds [119]. In dogs we studied 
indirectly the relationship between cardiac output and total 
blood volume during isonatric and hyponatric dialysis using an 
experimental design that delivered comparable rates of plasma 
volume contraction [89]. The cardiac output/blood volume 
relationship did not appear to be altered when using hyponatric 
dialysis solution in that at the hemodynamic endpoint, both 
cardiac output and total blood volume were similar to those 
measured during isonatric dialysis . 
Cardiac responses 
As reviewed above, the evidence suggests that chronotropic 
and inotropic cardiac compensatory mechanisms are of rela-
tively minor importance to blood pressure regulation during 
hypovolemic hypotension in nonuremic patients or animals. In 
further support of this contention, when we evaluated the 
hemodynamic response of conscious nonuremic and uremic 
dogs to isolated ultrafiltration, we found that an absence of 
tachycardia at the endpoint of ultrafiltration (after an initial 
increase in heart rate) was the normal , nonuremic response; in 
some uremic animals a marked tachycardia was induced by 
volume depletion , but this in no way improved tolerance to fluid 
removal [76]. However, hypovolemia induced by hemorrhage 
(or isolated ultrafiltration) and hypovolemia during dialysis are 
not completely identical conditions: as discussed below, during 
dialysis factors may be operative which cause an inappropriate 
decrease in total peripheral resistance. In such instances main-
tenance of blood pressure may depend on the ability of cardiac 
output to increase, and cardiac output may be not totally limited 
by venous return. Then changes in cardiac inotropy or rate 
might become important. 
The discussion of cardiac factors in dialysis hypotension has 
focused in three areas: (1) uremia-associated impairment of the 
heart rate increase in response to hypovolemia, (2) a possible 
cardiodepressant effect of acetate , and (3) the inotropic effect of 
changes in plasma K and Ca levels during hemodialysis . Im-
pairment of heart rate reflexes has been discussed above. 
Whether or not acetate has a clinically important cardiodepres-
sant effect is controversial. Certainly in vitro a depressant effect 
can be observed on both atrial contraction [120, 121] and on 
dP/dtmax in the isolated perfused rat heart [121]. However, 
during acetate dialysis in humans, decreased cardiac perfor-
mance may [110, 122-124] or may not [109, 125-127] be seen. 
Clinically the most important adverse cardiac effect of acetate 
may be on myocardial oxygen balance with the attendant 
possibility of provoking subendocardial ischemia [128]. 
Improvement in cardiac performance during dialysis has been 
documented in a number of studies, and it may be due to the 
decrease in serum potassium levels, as well as the increase 
ionized calcium levels which occur as a result of dialysis [129, 
130]. Calcium-associated changes in cardiac output have been 
linked to intradialytic blood pressure levels [130]. 
Vascular resistance 
A decrease in vascular resistance has been shown to be an 
important cause of dialysis hypotension [131]. The factors 
postulated to cause venous pooling discussed above all operate 
indirectly via their effect on resistance vessels. Some additional 
points about each of these factors, focusing on peripheral 
resistance, bear elaboration. 
Anemia. The blood viscosity increases exponentially with 
increasing hematocrit, and blood viscosity is an important 
component of peripheral vascular resistance [76]. For this 
reason, correction of anemia will increase vascular resistance 
and may help maintain it during dialysis. Also, correction of 
anemia might lead to regression of left ventricular hypertrophy, 
and possibly to resolution of that component of baroreflex 
dysfunction mediated by left ventricular hypertrophy. 
Acetate. Despite recent evidence by Maeda et al [104] that 
sudden hypotension during acetate dialysis is often preceded by 
a fall in cardiac output and not by a change in total peripheral 
vascular resistance (TPR), there is a large body of evidence that 
TPR with acetate dialysis is reduced. For example, all of the 
initial comparisons between acetate hemodialysis and isolated 
ultrafiltration or hemofiltration emphasized that the primary 
reason for reduced blood pressure during acetate dialysis was a 
decreased TPR [132-134]. In sympathectomized dogs, acetate 
dialysis provokes a transient cardiovascular collapse; very 
severe degrees of hypotension are seen despite a marked 
increase in cardiac output. Thus, the primary hemodynamic 
mechanism of hypotension due to acetate is probably a fall in 
TPR [108]. 
Temperature. During heat stress, the large obligatory in-
crease in cutaneous blood flow results in a reduced TPR and 
will cause hypotension unless cardiac output can increase 
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substantially. Although cutaneous blood pooling as described 
above might contribute to hypotension during dialysis due to 
heat stress, the fall in TPR is probably a more important 
phenomenon. 
The effect of temperature on TPR during dialysis is important 
when considering some of the published differences in hemo-
dynamic parameters during dialysis and hemofiltration. Al-
though TPR during bicarbonate dialysis is improved relative to 
acetate hemodialysis, in some studies TPR increased even more 
during hemofiltration than during bicarbonate dialysis [135]. An 
early popular hypothesis was that the excellent TPR response 
during hemofiltration might be due to removal from the blood of 
substances with vasodilatory properties. However, this hypoth-
esis was always difficult to reconcile with the excellent mainte-
nance of both blood pressure [136] and TPR [133] during 
isolated ultrafiltration. Experiments by Maggiore et al cleaved a 
Gordian knot when their data suggested that at least some of the 
hemodynamic differences between hemodialysis and hemofil-
tration might be due to a temperature factor. With hemofiltra-
tion, although the replacement fluid is warmed, cooling of blood 
in the extracorporeal circuit results in a fall in body tempera-
ture. With standard hemodialysis, the warmed dialysate pre-
vents cooling of blood in the extracorporeal circuit, and body 
temperature during dialysis usually increases slightly. Mag-
giore's group found that blood pressure during conventionally 
performed dialysis was indeed lower than that during hemofil-
tration; however, during thermic ally equivalent hemodialysis 
and hemofiltration there were no significant differences in blood 
pressure [137]. In Maggiore's experiments cardiac output and 
TPR were not measured, but several recent studies suggest that 
hemofiltration is not associated with a better TPR profile than 
bicarbonate hemodialysis [Ill, 138]. In dogs, hemodynamic 
comparison of "cool" versus "warm" isolated ultrafiltration 
shows that blood pressure during "cool" isolated ultrafiltration 
is better maintained due to an increased TPR [139]. However, 
body temperature regulatory mechanisms in dogs and humans 
are quite different, and corresponding hemodynamic studies 
need to be repeated in humans. 
Food ingestion. As noted above, ingestion of food during 
dialysis causes hypotension. Whether the mechanism of hypo-
tension is a reduced TPR due to decreased splanchnic resis-
tance, or decreased cardiac filling due to splanchnic blood 
pooling, is a somewhat moot point: Both effects are probably 
involved in the pathogenesis of food-induced hypotension. 
Other factors. Other dialysis-related factors possibly causing 
an impaired TPR response include intradialytic changes in 
plasma sodium, potassium, calcium. and acid-base composi-
tion. choice of dialyzer membrane. and use of antihypertensive 
drugs. 
a.) Sodium. The acute fall in plasma sodium level that occurs 
when low sodium dialysis solution is used might impair TPR 
response. but this question has never been studied in humans. 
In dogs. use oflow sodium dialysis solution does not result in an 
altered TPR response [89]. 
b.) Potassium. Henrich et al found that the fall in plasma 
potassium levels during dialysis was not linked to an adverse 
blood pressure response [140]. Pogglitsch and colleagues found 
that infusion of 10 to 20 mEq of potassium during the last 30 
minutes of dialysis reduced the incidence of hypotensive epi-
sodes [141]. These results at first appear paradoxic. as hy-
pokalemia should result in vasoconstriction [142]. Pogglitsch et 
al explained their results by postulating that hypokalemia might 
affect the release of norepinephrine or otherwise impair auto-
nomic reflexes. No hemodynamic studies are available; how-
ever. given that correction of hyperkalemia should increase, 
rather than impair myocardial performance [143], any hypoten-
sive effect of hypokalemia should operate by way of a reduced 
TPR. 
c.) Calcium. Calcium can affect vascular tone. and dialysate 
calcium levels might affect TPR directly; however, a recent 
study suggests that changes in blood calcium concentration 
during dialysis affect the blood pressure via an effect on cardiac 
output rather than on vascular resistance [130]. Modest lower-
ing of the dialysis solution calcium concentration has been 
shown to have measurable effect on intradialytic blood pressure 
levels [144]. 
d.) Acid-base composition. There has been much speculation 
as to possible roles for hypoxemia. as well as changes in blood 
P co, and pH levels during dialysis in the causation of dialysis 
hypotension. Certainly changes in blood acid-base composition 
can affect blood flow in a variety of vascular beds. However. 
several negative findings in this area have been published. We 
now know that the degree of intradialytic hypoxemia does not 
correlate with the amount of hypotension [145]. Our own group 
has found that high efficiency dialysis using an L-Iactate con-
taining dialysis solution was not associated with the adverse 
hemodynamic effects seen with acetate, despite the fact that 
both L-Iactate and acetate dialysis resulted in similar changes in 
blood p02 and acid-base composition [146]. 
e.) Membranes. This is a complex area. and includes the 
possible hemodynamic effects of dialyzer contaminants and 
sterilants, the possible hemodynamic effects of complement 
activation due to blood membrane interaction [reviewed in 147]. 
and the possible cardiovascular consequences of induction of 
synthesis of interleukin-l and tumor necrosis factor synthesis in 
monocytes [148. 149] during dialysis. Not much space is ac-
corded to all of the possibilities in the present review. as there 
is no sound (in my opinion [150]) evidence that blood pressure 
during dialysis is in any way affected by the type of dialyzer or 
membrane used (with the notable exception, of course. of 
anaphylactoid reactions when such are induced [151]). Note-
worthy are two recent negative studies in this regard [152. 153]. 
Because induction of interleukin-l and tumor necrosis factor 
takes several hours to occur. increased plasma levels of these 
compounds may peak hours into the post-dialysis period, and it 
is conceivable that these mediators may be partially responsible 
for the prolonged post-dialysis blood pressure decrease de-
scribed by Batlle, Von Riotte and Lang [154]; this question has 
not been studied. 
j:) Drugs. Various anti-hypertensive drugs may have a direct 
effect on veins and/or resistance vessels and also on barore-
flexes. The different effects of nifedipine, diltiazem. hydrochlo-
rothiazide. and clonidine on baroreflex responses are listed in 
Table 1. To date the problem of dialyzing hypertensive patients 
receiving antihypertensive drugs has been solved by withhold-
ing the drug prior to dialysis on dialysis days. However, several 
of the newer drugs have very prolonged half-lives, which may 
be even longer in dialysis patients due to impairment of renal 
drug excretion. 
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Sympathetic failure during hemodialysis 
The failure of plasma norepinephrine levels to rise appropri-
ately during dialysis was noted by Baldamus et al [155]. 
Maeda's group found that ultrafiltrate norepinephrine levels 
often fall, rather than increase, just prior to a hypotensive 
episode [156]. The hemodynamic correlates of these studies are 
different, because Baldamus et al linked the failure of the 
plasma norepinephrine level rise with a decreased TPR, 
whereas Maeda et al emphasized a decreased cardiac output, 
hypothesized to be due to venodilatation. 
Logically, the question of "sympathetic failure" during dial-
ysis can be divided into four areas: 
Sympathetic failure in non-uremic individuals 
So-called sympathetic failure during hypovolemia has been 
reported to occur in nonuremic humans with supposedly normal 
cardiovascular systems [12, 157]. The cause is presently un-
known, but may be related to activation of sympathodilator 
reflexes [158], or to hypotension-induced release of vasodila-
tory substances, including adenosine [159] or calcitonin-gene-
related peptide [160, 161), among others. 
Baroreflex dysfunction 
Diminished norepinephrine release during dialysis in uremic 
patients mayor may not be a manifestation of baroreflex 
dysfunction. As discussed above, the response of plasma nor-
epinephrine levels to tilt in uremic patients mayor may not be 
abnormal, depending on patient selection, especially as it 
pertains to presence or absence of diabetes, cardiac disease, 
and to patient age and to length of time on dialysis. 
Dialysis-related factors 
Certain dialysis-associated factors may inhibit the normal 
increase in plasma norepinephrine levels during dialysis. Such 
effects are revealed when alternative treatments such as hemo-
filtration are associated with a "normal" plasma norepineph-
rine response [155]. Possible antagonists to norepinephrine 
release include acetate, operating through an increased purine 
nucleoside turnover [162] via adenosine [163, 164]' eating, via 
unknown, possibly adenosine-related mechanisms, or increased 
body temperature. In one study in dogs, plasma norepinephrine 
levels during "cool" versus "warm" isolated ultrafiltration 
were similar, despite differences in hemodynamic responses 
[139], but plasma norepinephrine levels were measured only at 
a rather severe hypotensive endpoint. In humans, one group 
has found that with "cool" dialysis, the increase in plasma 
norepinephrine levels is accentuated [165]. 
Treatment 
Refractory dialysis hypotension has been successfully treated 
with either direct-acting alpha-adrenergic agents such as phe-
nylephrine [166] or with indirectly acting sympathomimetic 
agents such as amezinium [167, 168] or DOPS f169]. Such 
results suggest that the failure of plasma norepinephrine levels 
to increase is causally related to dialysis hypotension. 
Summary 
An analysis of the normal compensatory responses to hypo-
volemia reveals that central redistribution of the blood volume 
(due to changes in TPR and possibly also to venoconstriction) 
may be an important means of maintaining cardiac output. 
Chronotropic and inotropic cardiac changes during hypo-
volemia appear to play a relatively minor role in supporting 
blood pressure. Increased TPR is important in that it supports 
overall proximal blood pressure and also helps augment venous 
return. Cardiopulmonary and pressoreceptor reflexes are pri-
marily responsible for increasing TPR during volume depletion 
by increasing sympathetic nerve activity to resistance vessels . 
Cutaneous resistance and capacity are affected by body tem-
perature as well , and splanchnic resistance and capacity are 
modulated by both body temperature and by ingestion of food . 
In uremic patients, the most easily demonstrable evidence of 
baroreflex impairment, alteration of heart rate responses, may 
be hemodynamically the least relevant. Further studies of 
cardiopulmonary and pressoreceptor function as reflected by 
their effects on vascular resistance are needed. 
There are several treatment-associated causes of dialysis 
hypotension: With low sodium dialysis solution the primary 
cause of hypotensIon is probably a reduced plasma refilling 
rate , although studies of TPR and cardiac output have been 
done in dogs only. Acptate lowers the TPR, may impair plasma 
refilling , and may also induce pooling of blood in splanchnic and 
other capacitance beds, causing diminished cardiac filling and a 
relatively decreased cardiac output. Dialysis-associated heat 
stress may lower TPR and may also caUse blood pooling in the 
cutaneous vasculature. The .hemodynamic mechanism of post-
prandial hypotension in dialysis patients needs to be studied, 
but probably revolves around reduced splanchnic (and total 
peripheral) vascular resistance, and splanchnic blood pooling. 
Several other potential treatment-related causes of dialysis 
hypotension warrant further study. The most important candi-
dates include the role played by changes in the plasma potas-
sium level and the potential effects of monokines (lL-l and 
tumor necrosis factor) which may be released during dialysis . 
Also, whether adenosine [163 , 164], cGRP, and other vasoac-
tive peptides participate in the causation of "sympathetic 
failure" during dialysis hypotension warrants further investiga-
tion. 
Clinical recommendations 
At this point of incomplete knowledge, a number of practical 
suggestions can be made: Correction of anemia to a Hct of at 
least 30% may reduce hypotension in all patients. One should 
keep the dialysis solution sodium level close to the plasma 
level. Heat stressing a patient prior to dialysis -(for example, in 
the summertime, having the patient wait in a non-air-condi-
tioned room) should be avoided. One can attempt to lower the 
dialysis solution temperature slightly. If this results in patient 
discomfort and shivering, lowering dialysis solution tempera-
ture during the latter part of dialysis only may be of help . 
Limiting the length of the dialysis session (such as, to 3 hours, 
while using an appropriately high blood flow rate and large 
dialyzer to maintain an adequate KtlV) might lessen the time 
available for a build-up in core body heat, and might lessen the 
amount of cutaneous dilatation and hypotension during the 
latter part of dialysis (this is a hypothesis). One should avoid 
use of acetate dialysis solution whenever possible, especially 
when a high efficiency treatment is required. When a machine 
capable of performing bicarbonate dialysis is not available , the 
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possibility of using L-Iactate as an alternative base merits 
consideration [146], although further studies of L-Iactate dIaly-
sis are needed. In hypotension prone patients, ingestion offood 
or glucose-containing beverages immediately prior to or during 
dialysis should be avoided. In patients in whom the primary 
problem is orthostatic hypotension after dialysis, a program of 
exercises designed to increase leg muscle tone may be of benefit 
in helping maintain venous return during standing or sitting. 
. There is no compelling reason to turn to either isolated 
ultrafiltration or hemofiltration with the goal of increasing 
vascular stability; previously reported hemodynamic advan-
tages for these therapies were probably due primarily to avoid-
ance of acetate and to a temperature effect. At present there is 
insufficient evidence to warrant recommending any type or 
group of dialyzer membranes with the goal of optimizing 
hemodynamic response. The efficacy and safety of sympatho-
mimetic agents in treating refractory dialysis hypotension needs 
further investigation. 
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